Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilie Routier

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Current Oncology Reports|June 2, 2023
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on MelanomaCéline Boutros, Djaouida Belkadi-Sadou, Antoine Marchand, et al.
Critical Reviews in Oncology/Hematology|March 21, 2016
Impact of dermatologic adverse events induced by targeted therapies on quality of lifeCécile Charles, Catherine Bungener, Darius Razavi, et al.
Investigational New Drugs|April 2, 2014
Kidney injuries related to ipilimumabHassane Izzedine, Victor Gueutin, Chems Gharbi, et al.
JAMA Dermatology|May 24, 2013
Vemurafenib and radiosensitizationLise Boussemart, Catherine Boivin, Joël Claveau, et al.
European Journal of Dermatology : EJD|February 12, 2010
Nosocomial disseminated Mycobacterium chelonae infection in an immunocompromised patientEmilie Sbidian, Nora Kramkimel, Emilie Routier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2022
Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1Caroline Robert, Céleste Lebbé, Thierry Lesimple, et al.
Cell Reports|November 25, 2020
Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid OxidationShensi Shen, Sara Faouzi, Sylvie Souquere, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2015
Two cases of immune thrombocytopenia associated with pembrolizumabAudrey Le Roy, Emmanuelle Kempf, Felix Ackermann, et al.
Alimentary Pharmacology & Therapeutics|December 28, 2022
Severe colitis in patients with melanoma treated with BRAF/MEK inhibitorsFranck Carbonnel, Emilie Routier, Thierry Lazure, et al.
Infection|December 3, 2016
Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patientDaniela Gavril, Paul-Louis Woerther, Aicha Ben Lakhdar, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Current Oncology Reports|June 2, 2023
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on MelanomaCéline Boutros, Djaouida Belkadi-Sadou, Antoine Marchand, et al.
Critical Reviews in Oncology/Hematology|March 21, 2016
Impact of dermatologic adverse events induced by targeted therapies on quality of lifeCécile Charles, Catherine Bungener, Darius Razavi, et al.
Investigational New Drugs|April 2, 2014
Kidney injuries related to ipilimumabHassane Izzedine, Victor Gueutin, Chems Gharbi, et al.
JAMA Dermatology|May 24, 2013
Vemurafenib and radiosensitizationLise Boussemart, Catherine Boivin, Joël Claveau, et al.
European Journal of Dermatology : EJD|February 12, 2010
Nosocomial disseminated Mycobacterium chelonae infection in an immunocompromised patientEmilie Sbidian, Nora Kramkimel, Emilie Routier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2022
Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1Caroline Robert, Céleste Lebbé, Thierry Lesimple, et al.
Cell Reports|November 25, 2020
Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid OxidationShensi Shen, Sara Faouzi, Sylvie Souquere, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2015
Two cases of immune thrombocytopenia associated with pembrolizumabAudrey Le Roy, Emmanuelle Kempf, Felix Ackermann, et al.
Alimentary Pharmacology & Therapeutics|December 28, 2022
Severe colitis in patients with melanoma treated with BRAF/MEK inhibitorsFranck Carbonnel, Emilie Routier, Thierry Lazure, et al.
Infection|December 3, 2016
Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patientDaniela Gavril, Paul-Louis Woerther, Aicha Ben Lakhdar, et al.
Pageof 5